The PARP (Poly ADP-Ribose Polymerase) Inhibitors Market is witnessing significant growth and a surge in demand, fueled by a combination of evolving treatment paradigms, increasing prevalence of cancer, and advancements in precision medicine. According to recent market analysis, several key factors are driving this remarkable expansion. Market Growth and Demand: Rising Prevalence of Cancer: The...